Bispecific antibodies (bsAbs) are artificial antibodies with two distinct antigen-binding sites
that can bind to different antigens or different epitopes on the same antigen. Based on a …

Bispecific antibodies (BsAbs) are a sort of dual functional proteins with specific binding to
two distinct targets, which have become a focus of interest in antibody engineering and drug …

Development of cancers mostly involves more than one signal pathways, because of the
complicated nature of cancer cells. As such, the most effective treatment option is the one …

A bispecific antibody (BsAb) is an artificial protein containing two kinds of specific antigen
binding sites. BsAb can connect target cells to functional cells or molecules, and thus …

Bispecific antibodies (BsAbs) are antibodies with two binding sites directed at two different
antigens or two different epitopes on the same antigen. The clinical therapeutic effects of …

In past years, both laboratory and early clinical studies have demonstrated that bispecific
antibodies (BsAbs) may have significant potential application in cancer therapy either by …

Bispecific antibodies, in contrast to conventional monoclonal antibodies, can bind
simultaneously two different antigens. Taking advantage of this virtue, they are mostly …

Targeted cellular immunotherapy with bifunctional antibodies (bsAbs) has emerged as a
promising therapeutic approach for cancer over the last two decades. Progress in antibody …

Bispecific antibody (BsAb) usually consists of two different antigen-binding arms, by which it
is capable of simultaneously binding to target cells and effector cells, and can directly …

Bispecific antibodies poised to deliver wave of cancer therapies. - Document - Gale OneFile:
Health and Medicine Use this link to get back to this page. Copy Skip to Content Sign in bar …